Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zidovudine, IL-2, and Ganciclovir for AIDS-related PCNSL
NCT00006264Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Jul 2000
- Primary completion
- Mar 2003
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of zidovudine, ganciclovir, aldesleukin in primary central nervous system lymphoma (PCNSL), sponsored by AIDS Malignancy Consortium. Started Jul 2000; status: completed.
02
Drugs
zidovudinegancicloviraldesleukin
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00006264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006264.